These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27025981)

  • 1. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The missing piece in the puzzle: Prediction of aggregation via the protein-protein interaction parameter A
    Koepf E; Schroeder R; Brezesinski G; Friess W
    Eur J Pharm Biopharm; 2018 Jul; 128():200-209. PubMed ID: 29723667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.
    Vaclaw C; Merritt K; Griffin VP; Whitaker N; Gokhale M; Volkin DB; Ogunyankin MO; Dhar P
    AAPS PharmSciTech; 2023 Apr; 24(5):104. PubMed ID: 37081185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Combined Impact of Temperature and Application of Interfacial Dilatational Stresses on Surface-mediated Protein Particle Formation in Monoclonal Antibody Formulations.
    Griffin VP; Merritt K; Vaclaw C; Whitaker N; Volkin DB; Ogunyankin MO; Pace S; Dhar P
    J Pharm Sci; 2022 Mar; 111(3):680-689. PubMed ID: 34742729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.
    Telikepalli S; Kumru OS; Kim JH; Joshi SB; O'Berry KB; Blake-Haskins AW; Perkins MD; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):495-507. PubMed ID: 25522000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notorious but not understood: How liquid-air interfacial stress triggers protein aggregation.
    Koepf E; Eisele S; Schroeder R; Brezesinski G; Friess W
    Int J Pharm; 2018 Feb; 537(1-2):202-212. PubMed ID: 29288093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.
    Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF
    J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and analysis of aggregates in a liquid IgG1-antibody formulation.
    Mahler HC; Müller R; Friess W; Delille A; Matheus S
    Eur J Pharm Biopharm; 2005 Apr; 59(3):407-17. PubMed ID: 15760721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of formulation pH on physicochemical protein characteristics at the liquid-air interface.
    Koepf E; Richert M; Braunschweig B; Schroeder R; Brezesinski G; Friess W
    Int J Pharm; 2018 Apr; 541(1-2):234-245. PubMed ID: 29486287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both protein adsorption and aggregation contribute to shear yielding and viscosity increase in protein solutions.
    Castellanos MM; Pathak JA; Colby RH
    Soft Matter; 2014 Jan; 10(1):122-31. PubMed ID: 24651563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Impact of Combined Hydrodynamic Shear and Interfacial Dilatational Stress, on Interface-Mediated Particle Formation for Monoclonal Antibody Formulations.
    Griffin VP; Pace S; Ogunyankin MO; Holstein M; Hung J; Dhar P
    J Pharm Sci; 2024 Aug; 113(8):2081-2092. PubMed ID: 38615816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Adsorption and Layer Formation at the Stainless Steel-Solution Interface Mediates Shear-Induced Particle Formation for an IgG1 Monoclonal Antibody.
    Kalonia CK; Heinrich F; Curtis JE; Raman S; Miller MA; Hudson SD
    Mol Pharm; 2018 Mar; 15(3):1319-1331. PubMed ID: 29425047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Effect of Cavitation and Agitation on Protein Aggregation.
    Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S
    J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.